https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MS.jpg

Infusion Therapy Market Analysis, Size, Trends | Europe | 2020-2026 | COVID19 | MedSuite

  • Year: 2020
  • Scope: 2016-2026
  • Region: Europe
  • Pages: 558
  • Published Date: 10/16/2020
  • Type: MedSuite

In 2020, the European infusion therapy device market size was valued at almost €927 billion, with over 137 million intravenous pump sets sold every year. In spite of COVID19, the market size is expected to increase at a compound annual growth rate (CAGR) of 1.3% to reach €1.1 billion in 2026.

Throughout this medical market research, we analyzed 46 infusion therapy companies across Europe and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all the EU Infusion Therapy market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Market Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each Infusion Therapy market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact On the European Infusion Therapy Market
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Infusion Therapy Market Insights

The expansion of alternate care is expected to somewhat offset the negative impact caused by COVID-19 over the forecast period. Many healthcare markets are already trending towards alternate care since it relieves some of the strain that is placed on hospitals. During a global health pandemic, this becomes especially important. Furthermore, alternate care settings tend to pay higher prices per device compared to acute care, which drives up the total market ASP.

EU Infusion Therapy Market Size by Segment, 2016-2026

Currently, the standard of care for infusions in Europe is gravity drip infusion, administered through a gravity set. However, sales of pump sets have been growing faster and are growing in terms of share of total infusions performed. Over the course of the forecast period, this trend is expected to continue and it is possible that over a long enough period of time, pump infusions may become the standard of care in many European countries.

COVID19 Impact on the Infusion Therapy Market in Europe

COVID-19 is expected to play a significant role in this market throughout the forecast period. Due to a lower number of elective procedures, as well as restrictions limiting sales representatives and technicians from entering hospitals, many facilities have been delaying the purchase of new medical devices such as infusion pumps. This is expected to have a negative impact on the infusion pump market in 2020 and 2021. Since infusion pump sales make up a sizable portion of the total market value, the infusion therapy device market is expected to take a downturn in these years as well.

Infusion Therapy Market Share Insight

EU Infusion Therapy Market Share Leaders

B. Braun was the leading competitor in the total European infusion therapy device market by 2020. B. Braun’s largest revenues were in the IV set and infusion pump markets, but the company also led the market for stopcocks.

Becton Dickinson was the second-leading competitor in the European market. The company was involved in most of the infusion therapy markets covered in this research and was strongest in the large volume infusion pump segment in 2019.

The third leading competitor in the European infusion therapy market was Fresenius Kabi. The company has been experiencing strong growth due to its lower manufacturing costs, which has translated into lower prices for hospitals and GPOs.

RESEARCH REGIONAL COVERAGE

Throughout this research series, iData Research has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The countries covered are:

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Scandinavia (Norway, Finland, Sweden, and Denmark)
  • Switzerland
  • Austria
  • Portugal

SEGMENTS COVERED

Feel free to click on each title to view detailed market segmentation. Please note that the analysis of each of the Infusion Therapy market segments can be purchased as separate reports, MedCores.

  • Infusion Pump Market – MedCore – The market analysis is further broken down by:
    • Product Type: Large Volume Pumps, Syringe Pumps, Patient-Controlled Analgesia Pumps, Electronic Ambulatory Pumps, and Disposable Ambulatory Pumps;
    • Care Setting:  Acute and Alternate Care Settings.
  • Intravenous Set Market – MedCore – The market is comprised of the segments broken down by:
    • Product Type: Pump Sets,  Gravity Sets, Secondary Sets, and Extension Sets;
    • Care Setting: Acute and Alternate Care Settings
  • Needleless Connector Market – MedCore – The market is further segmented by:
    • Displacement Type: Negative, Positive, and Neutral Displacement;
    • Delivery Type: Standalone and Integrated;
    • Care Setting: Acute and Alternate Care Settings.
  • Stopcock Market – MedCore – The in-depth analysis of the Stopcock Market.
  • Blood Transfusion Set Market – MedCore – The chapter provides an overview of the Blood Transfusion Set market.

Detailed Market Segmentation


EU Infusion Therapy Market Segmentation - p1
EU Infusion Therapy Market Segmentation - p2

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

TABLE OF CONTENTS FOR THE EU INFUSION THERAPY MARKET REPORT SUITE

TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XXIX
EXECUTIVE SUMMARY 1
EUROPEAN INFUSION THERAPY DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 7
MARKETS INCLUDED 8
KEY REPORT UPDATES 10
VERSION HISTORY 11
RESEARCH METHODOLOGY 12
Step 1: Project Initiation & Team Selection 12
Step 2: Prepare Data Systems and Perform Secondary Research 15
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25

IMPACT OF COVID-19 ON THE EUROPEAN INFUSION THERAPY DEVICE MARKET

2.1 INTRODUCTION 26
2.2 MULTI-SCENARIO ANALYSIS 28
2.2.1.1 Best Case Scenario 28
2.2.1.2 Base Case Scenario 30
2.2.1.3 Worst Case Scenario 32

DISEASE OVERVIEW

3.1.1 Congestive Heart Failure 35
3.1.2 Crohn’s Disease 36
3.1.3 Hemophilia 37
3.1.4 Immune Deficiencies 38
3.1.5 Multiple Sclerosis 38
3.1.6 Cancer 39

PRODUCT ASSESSMENT

4.1 INTRODUCTION 42
4.2 PRODUCT PORTFOLIOS 42
4.2.1 Large Volume Infusion Pump 42
4.2.2 Syringe Pumps 44
4.2.3 Patient-Controlled Analgesia Pumps 46
4.2.4 Electronic Ambulatory Pumps 48
4.2.5 Disposable Ambulatory Infusion Pump 50
4.2.6 Intravenous Sets 51
4.2.6.1 Pump Sets 51
4.2.6.2 Gravity Sets 51
4.2.6.3 Secondary Sets 52
4.2.6.4 Extension Sets 52
4.2.7 Needleless Connectors 54
4.2.7.1 Split Septum and Blunt Cannula 54
4.2.7.2 Mechanical Valves 54
4.2.7.3 Negative Displacement Mechanical Valves 55
4.2.7.4 Positive Displacement Mechanical Valves 55
4.2.7.5 Neutral Displacement Mechanical Valves 55
4.2.7.6 Anti-Reflux Neutral Displacement Mechanical Valves 55
4.2.7.7 Antimicrobial Needleless Connectors 56
4.2.8 Stopcocks 57
4.2.9 Intravenous Filters 58
4.2.10 Blood Transfusion Devices 59
4.2.10.1 Blood Transfusion Sets 59
4.2.10.2 Blood Warmers 60
4.3 FDA RECALLS 62
4.3.1 Argon Medical Devices 62
4.3.1.1 Stopcocks 62
4.3.2 Baxter 63
4.3.2.1 Infusion Pump 63
4.3.2.2 Intravenous Sets 65
4.3.2.3 Needleless Connectors 66
4.3.2.4 Blood Transfusion Devices 66
4.3.3 Becton Dickinson 67
4.3.3.1 Intravenous Sets 67
4.3.3.2 Infusion Pumps 68
4.3.4 Fresenius 68
4.3.4.1 Infusion Pumps 68
4.3.5 ICU Medical 69
4.3.5.1 Infusion Pumps 69
4.3.5.2 Intravenous Sets 69
4.3.6 Medtronic 71
4.3.6.1 Intravenous Sets 71
4.3.7 MOOG Corporation 72
4.3.7.1 Intravenous Sets 72
4.3.8 Smiths Medical 73
4.3.8.1 Infusion Pump 73
4.3.8.2 Intravenous Sets 75
4.3.8.3 Stopcocks 75
4.3.9 Vygon USA 76
4.3.9.1 Intravenous Sets 76
4.3.9.2 Stopcocks 76
4.3.10 Zyno Medical Products 77
4.3.10.1 Intravenous Sets 77
4.4 CLINICAL TRIALS 78
4.4.1 Careggi Hospital 79
4.4.2 Jeffrey N. Bruce 79
4.4.3 Johaan Wolfgang Goethe University Hospital 80
4.4.4 Mahidol University 80
4.4.5 Medallion Therapeutics, Inc. 81
4.4.6 Memorial Sloan Kettering Cancer Center 82
4.4.7 Michael J Cavnar, MD 83
4.4.8 National Cancer Institute 84
4.4.9 Octapharma 85
4.4.10 Xiangya Hospital of Central South University 86
4.4.11 Yonsei University 86

EUROPEAN INFUSION THERAPY DEVICE MARKET OVERVIEW

5.1 INTRODUCTION 88
5.2 CURRENCY EXCHANGE RATE 89
5.3 MARKET OVERVIEW 90
5.4 TREND ANALYSIS BY SEGMENT 96
5.5 DRIVERS AND LIMITERS 99
5.5.1 Market Drivers 99
5.5.2 Market Limiters 100
5.6 COMPETITIVE MARKET SHARE ANALYSIS 103
5.7 MERGERS AND ACQUISITIONS 110
5.8 COMPANY PROFILES 112
5.8.1 Avanos Medical 112
5.8.2 Baxter 113
5.8.3 B. Braun 114
5.8.4 Becton Dickinson 115
5.8.5 ICU Medical 117
5.8.6 Smiths Medical 118
5.9 SWOT ANALYSIS 119
5.9.1 Avanos Medical 120
5.9.2 Baxter 121
5.9.3 B. Braun 122
5.9.4 Becton Dickinson 123
5.9.5 ICU Medical 124
5.9.6 Smiths Medical 125

COUNTRY PROFILES

6.1 INTRODUCTION 126
6.1.1 Population 126
6.1.2 GDP Per Capita 126
6.1.3 Price Index 126
6.2 GERMANY 127
6.3 FRANCE 128
6.4 UNITED KINGDOM 129
6.5 ITALY 130
6.6 SPAIN 131
6.7 BENELUX 132
6.8 SCANDINAVIA 133
6.9 AUSTRIA 134
6.10 SWITZERLAND 135
6.11 PORTUGAL 136

INFUSION PUMP MARKET

7.1 INTRODUCTION 137
7.1.1 Large Volume Infusion Pumps 138
7.1.2 Syringe Infusion Pumps 139
7.1.3 Patient-Controlled Analgesia Infusion Pumps 139
7.1.4 Electronic Ambulatory Infusion Pumps 139
7.1.5 Disposable Ambulatory Infusion Pumps 140
7.2 MARKET OVERVIEW 141
7.3 MARKET ANALYSIS AND FORECAST 147
7.3.1 Total Large Volume Infusion Pump Market 147
7.3.1.1 Large Volume Infusion Pump Market by Care Setting 155
7.3.1.1.1 Acute Care Large Volume Infusion Pump Market 158
7.3.1.1.2 Alternate Care Large Volume Infusion Pump Market 165
7.3.2 Total Syringe Infusion Pump Market 172
7.3.2.1 Syringe Infusion Pump Market by Care Setting 180
7.3.2.1.1 Acute Care Syringe Infusion Pump Market 183
7.3.2.1.2 Alternate Care Syringe Infusion Pump Market 190
7.3.3 Total Patient-Controlled Analgesia Infusion Pump Market 197
7.3.4 Total Electronic Ambulatory Infusion Pump Market 204
7.3.4.1 Electronic Ambulatory Infusion Pump Market by Care Setting 212
7.3.4.1.1 Acute Care Electronic Ambulatory Infusion Pump Market 215
7.3.4.1.2 Alternate Care Electronic Ambulatory Infusion Pump Market 222
7.3.5 Total Disposable Ambulatory Infusion Pump Market 229
7.3.5.1 Disposable Ambulatory Infusion Pump Market by Type 236
7.3.5.2 Non-Pain Disposable Ambulatory Infusion Pump Market 240
7.3.5.3 Pain Disposable Ambulatory Infusion Pump Market 247
7.4 UNIT ANALYSIS 254
7.4.1 Large Volume Infusion Pump Units by Purchase Type 254
7.4.1.1 Purchased Large Volume Infusion Pump Units 256
7.4.1.2 Placement Plan Large Volume Infusion Pump Units 257
7.4.2 Syringe Infusion Pump Units by Purchase Type 258
7.4.2.1 Purchased Syringe Infusion Pump Units 261
7.4.2.2 Placement Plan Syringe Infusion Pump Units 262
7.4.3 Disposable Ambulatory Infusion Pump Units by Care Setting 263
7.4.3.1 Acute Care Disposable Ambulatory Infusion Pump Units 266
7.4.3.2 Alternate Care Disposable Ambulatory Infusion Pump Units 267
7.5 DRIVERS AND LIMITERS 268
7.5.1 Market Drivers 268
7.5.2 Market Limiters 269
7.6 COMPETITIVE MARKET SHARE ANALYSIS 271

INTRAVENOUS SET MARKET

8.1 INTRODUCTION 282
8.2 MARKET OVERVIEW 283
8.3 MARKET ANALYSIS AND FORECAST 288
8.3.1 Total Pump Intravenous Set Market 288
8.3.1.1 Pump Intravenous Set Market by Care Setting 296
8.3.1.1.1 Acute Care Pump Intravenous Set Market 299
8.3.1.1.2 Alternate Care Pump Intravenous Set Market 306
8.3.1.2 Pump Intravenous Set Market by Device Type 313
8.3.1.2.1 Dedicated Pump Intravenous Set Market by Pump Type 316
8.3.1.2.2 Non-Dedicated Pump Intravenous Set Market 340
8.3.2 Total Gravity Intravenous Set Market 347
8.3.2.1 Gravity Intravenous Set Market by Care Setting 355
8.3.2.1.1 Acute Care Gravity Intravenous Set Market 358
8.3.2.1.2 Alternate Care Gravity Intravenous Set Market 365
8.3.2.2 Gravity Intravenous Set Market by Device Type 372
8.3.2.2.1 Gravity Set with Airstop Market 375
8.3.2.2.2 Gravity Set without Airstop Market 382
8.3.3 Total Secondary Intravenous Set Market 389
8.3.3.1 Secondary Intravenous Set Market by Care Setting 397
8.3.3.1.1 Acute Care Secondary Intravenous Set Market 400
8.3.3.1.2 Alternate Care Secondary Intravenous Set Market 407
8.3.4 Total Extension Intravenous Set Market 414
8.3.4.1 Extension Intravenous Set Market by Care Setting 421
8.3.4.1.1 Acute Care Extension Intravenous Set Market 424
8.3.4.1.2 Alternate Care Extension Intravenous Set Market 431
8.4 DRIVERS AND LIMITERS 438
8.4.1 Market Drivers 438
8.4.2 Market Limiters 439
8.5 COMPETITIVE MARKET SHARE ANALYSIS 441

NEEDLELESS CONNECTOR MARKET

9.1 INTRODUCTION 447
9.2 MARKET OVERVIEW 449
9.2.1 Market Overview by Displacement Type 449
9.2.2 Market Overview by Device Type 455
9.2.3 Market Overview by Care Setting 460
9.3 MARKET ANALYSIS AND FORECAST 465
9.3.1 Total Needleless Connector Market 465
9.3.2 Needleless Connector Market by Displacement Type 473
9.3.2.1 Negative Displacement Needleless Connector Market 473
9.3.2.2 Positive Displacement Needleless Connector Market 480
9.3.2.3 Neutral Displacement Needleless Connector Market 487
9.3.3 Needleless Connector Market by Device Type 494
9.3.3.1 Standalone Needleless Connector Market 494
9.3.3.2 Integrated Needleless Connector Market 501
9.3.4 Needleless Connector Market by Care Setting 508
9.3.4.1 Acute Care Needleless Connector Market 508
9.3.4.2 Alternate Care Needleless Connector Market 515
9.4 DRIVERS AND LIMITERS 522
9.4.1 Market Drivers 522
9.4.2 Market Limiters 523
9.5 COMPETITIVE MARKET SHARE ANALYSIS 525

STOPCOCK MARKET

10.1 INTRODUCTION 529
10.2 MARKET ANALYSIS AND FORECAST 531
10.3 DRIVERS AND LIMITERS 539
10.3.1 Market Drivers 539
10.3.2 Market Limiters 539
10.4 COMPETITIVE MARKET SHARE ANALYSIS 541

APPENDIX: BLOOD TRANSFUSION SETS

11.1 INTRODUCTION 546
11.2 MARKET ANALYSIS AND FORECAST 547
11.3 DRIVERS AND LIMITERS 555
11.3.1 Market Drivers 555
11.3.2 Market Limiters 555

ABBREVIATIONS

The Infusion Therapy Market Report Suite| Europe | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • Acromedical
  • Applied Medical
  • AMS Ltd. UK
  • Aries
  • B. Braun
  • Baxter
  • Becton Dickinson
  • Benefis
  • Bexen Medical
  • Biolena
  • BMS Critical Care
  • BQ Plus
  • C.V. Medica
  • Cair
  • Codan
  • Crest Medical
  • Fresenius Kabi
  • Delta Med
  • Didactic
  • Doran
  • Fannin
  • Ferrari L. Medical Devices
  • Hospital Services
  • ICU Medical
  • IMS Euro
  • Intervene
  • Kimal
  • Klinicom
  • Leventon
  • Macropharm
  • McKinley Medical
  • Mediplus
  • Medispo
  • Micrel
  • Moog
  • Multimedia
  • Poly Medicure
  • Rays
  • S.M.D.
  • Sares
  • Shermond
  • Smiths Medical
  • Terumo
  • Vygon
  • Walkmed
  • Woo Young Medical

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology